Ratings by D. Boral Capital (Jason Kolbert)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/5/2026 | Reviva Pharmaceuticals | RVPH | Downgrade | Hold (Buy) |
0.24 (0.18) |
-25% | Details | |
| 3/4/2026 | Tevogen Bio | TVGN | Downgrade | Hold (Buy) |
0.25 (7.31) |
2824% | Details | |
| 3/3/2026 | Tevogen Bio | TVGN | Maintain | Buy (N/A) |
|
Details | ||
| 2/19/2026 | GeoVax Labs Inc. | GOVX | Downgrade | Hold (Buy) |
1.39 (1.79) |
28.78% | Details | |
| 2/6/2026 | Collplant Holdings Inc. | CLGN | Downgrade | Hold (Buy) |
0.75 (0.61) |
-18.67% | Details | |
| 2/5/2026 | OS Therapies, Inc | OSTX | New Coverage | Buy (N/A) |
1.33 (1.57) |
18.05% | Details | |
| 1/30/2026 | Quince Therapeutics Inc. | QNCX | Downgrade | Hold (Buy) |
0.27 (0.10) |
-62.96% | Details | |
| 12/29/2025 | Turn Therapeutics | TTRX | New Coverage | Buy (N/A) |
2.74 (3.50) |
27.74% | Details | |
| 12/24/2025 | Can-Fite BioPharma | CANF | Downgrade | Hold (Buy) |
0.24 (4.55) |
1795.83% | Details | |
| 11/25/2025 | Invivyd Inc. | IVVD | Downgrade | Hold (Buy) |
2.40 (1.80) |
-25% | Details | |
| 11/24/2025 | Enlivex Therapeutics | ENLV | Downgrade | Hold (Buy) |
0.90 (1.14) |
26.67% | Details | |
| 11/18/2025 | Cero Therapeutics | CERO | Downgrade | Hold (Buy) |
0.10 (0.10) |
0% | Details | |
| 11/6/2025 | UroGen Pharma | URGN | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2025 | Biomea Fusion Inc. | BMEA | Maintain | Buy (N/A) |
|
Details | ||
| 10/20/2025 | CorMedix | CRMD | Upgrade | Buy (Hold) |
10.18 (6.46) |
-36.54% | Details | |
| 10/17/2025 | MultiSensor AI Holdings Inc | MSAI | New Coverage | Buy (N/A) |
0.51 (0.30) |
-41.18% | Details | |
| 9/15/2025 | American Resources Corp. | AREC | New Coverage | Buy (N/A) |
2.03 (3.14) |
54.68% | Details | |
| 9/9/2025 | Veritone | VERI | Maintain | Buy (N/A) |
|
Details | ||
| 9/8/2025 | Artelo Biosciences, Inc. | ARTL | Downgrade | Hold (Buy) |
4.51 (1.14) |
-74.72% | Details | |
| 9/5/2025 | Avita Medical Ltd. | RCEL | Maintain | Buy (N/A) |
|
Details | ||
| 9/3/2025 | Plus Therapeutics Inc. | PSTV | Upgrade | Buy (Hold) |
0.43 (0.29) |
-32.56% | Details | |
| 9/2/2025 | Veritone | VERI | New Coverage | Buy (N/A) |
3.05 (2.98) |
-2.3% | Details | |
| 8/28/2025 | Vertical Aerospace Ltd. | EVTL | New Coverage | Buy (N/A) |
4.96 (4.01) |
-19.15% | Details | |
| 8/22/2025 | NRx Pharmaceuticals, Inc. | NRXP | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2025 | CervoMed | CRVO | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2025 | Artelo Biosciences, Inc. | ARTL | Maintain | Buy (N/A) |
|
Details | ||
| 7/8/2025 | Artelo | ARTL | Upgrade | Buy (Hold) |
14.32 (4.51) |
-68.51% | Details | |
| 6/30/2025 | CorMedix | CRMD | Downgrade | Hold (Buy) |
12.50 (10.18) |
-18.56% | Details | |
| 6/23/2025 | Cero Therapeutics | CERO | Upgrade | Buy (Hold) |
10.68 (0.10) |
-99.06% | Details | |
| 6/11/2025 | Artelo Biosciences | ARTL | Downgrade | Hold (Buy) |
1.13 (14.32) |
1167.26% | Details | |
| 5/30/2025 | Cero Therapeutics | CERO | Downgrade | Hold (Buy) |
0.52 (10.68) |
1953.85% | Details | |
| 5/23/2025 | Nano-X Imaging | NNOX | Maintain | Buy (N/A) |
|
Details | ||
| 5/20/2025 | Reviva Pharmaceuticals | RVPH | Maintain | Buy (N/A) |
|
Details | ||
| 5/19/2025 | Immunome Inc. | IMNM | Downgrade | Hold (Buy) |
8.06 (21.04) |
161.04% | Details | |
| 5/13/2025 | Immunome Inc. | IMNM | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2025 | NeuroSense Therapeutics Ltd. | NRSN | New Coverage | Buy (N/A) |
1.04 (0.87) |
-16.35% | Details | |
| 5/12/2025 | Medicus Pharma Ltd. | MDCX | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2025 | Plus Therapeutics Inc. | PSTV | Downgrade | Hold (Buy) |
0.65 (0.43) |
-33.85% | Details | |
| 4/22/2025 | Cero Therapeutics | CERO | New Coverage | Buy (N/A) |
0.64 (0.10) |
-84.38% | Details | |
| 4/14/2025 | Medicus Pharma Ltd. | MDCX | New Coverage | Buy (N/A) |
3.58 (0.39) |
-89.11% | Details | |
| 4/11/2025 | Scilex Holding Co. | SCLX | Downgrade | Hold (Buy) |
0.25 (8.48) |
3292% | Details | |
| 4/1/2025 | Reviva Pharmaceuticals | RVPH | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2025 | Quince Therapeutics Inc. | QNCX | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2025 | Plus Therapeutics Inc. | PSTV | New Coverage | Buy (N/A) |
0.68 (0.29) |
-57.35% | Details | |
| 3/10/2025 | Checkpoint Therapeutics | CKPT | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2025 | Pulmonx Corp. | LUNG | New Coverage | Buy (N/A) |
7.48 (2.02) |
-72.99% | Details | |
| 3/4/2025 | Tevogen Bio | TVGN | New Coverage | Buy (N/A) |
1.18 (0.25) |
-78.81% | Details | |
| 2/20/2025 | Avita Medical Ltd. | RCEL | Maintain | Buy (N/A) |
|
Details | ||
| 2/19/2025 | CervoMed | CRVO | Upgrade | Buy (Hold) |
2.23 (4.11) |
84.3% | Details | |
| 2/18/2025 | Estrella Immunopharma, Inc. | ESLA | New Coverage | Buy (N/A) |
1.24 (1.07) |
-13.71% | Details | |
| 2/10/2025 | Annovis Bio Inc. | ANVS | Downgrade | Hold (Buy) |
2.94 (2.49) |
-15.31% | Details | |
| 1/27/2025 | Scilex Holding Co. | SCLX | New Coverage | Buy (N/A) |
0.44 (0.25) |
-43.18% | Details | |
| 1/13/2025 | Checkpoint Therapeutics | CKPT | New Coverage | Buy (N/A) |
3.16 (4.26) |
34.81% | Details | |
| 1/13/2025 | CorMedix | CRMD | New Coverage | Buy (N/A) |
11.19 (12.50) |
11.71% | Details | |
| 1/6/2025 | Nano-X Imaging | NNOX | New Coverage | Buy (N/A) |
9.25 (2.70) |
-70.81% | Details | |
| 12/30/2024 | Citius Pharmaceuticals | CTXR | Upgrade | Buy (Hold) |
3.68 (0.84) |
-77.17% | Details | |
| 12/23/2024 | Omeros Corp. | OMER | New Coverage | Buy (N/A) |
10.31 (11.54) |
11.93% | Details | |
| 12/10/2024 | CervoMed | CRVO | Downgrade | Hold (Buy) |
10.25 (2.23) |
-78.24% | Details | |
| 12/4/2024 | Coya Therapeutics | COYA | New Coverage | Buy (N/A) |
6.04 (4.79) |
-20.7% | Details | |
| 12/2/2024 | MediciNova | MNOV | New Coverage | Buy (N/A) |
2.07 (1.36) |
-34.3% | Details | |
| 11/25/2024 | Context Therapeutics | CNTX | New Coverage | Buy (N/A) |
1.39 (3.12) |
124.46% | Details | |
| 11/18/2024 | CervoMed | CRVO | New Coverage | Buy (N/A) |
10.77 (10.25) |
-4.83% | Details | |
| 11/18/2024 | Lineage Cell Therapeutics Inc. | LCTX | New Coverage | Buy (N/A) |
0.86 (1.85) |
115.12% | Details | |
| 11/11/2024 | Carisma Therapeutics Inc | CARM | Maintain | Buy (N/A) |
|
Details |
